Results of ranibizumab treatment for choroidal neovascularization secondary to pathological myopia;Ergebnisse der Therapie choroidaler Neovaskularisationen bei pathologischer Myopie mit Ranibizumab

Klinische Monatsblatter fur Augenheilkunde

Volumn 228, Issue 4, 2011, Pages 284-287

  Hefner, L ^a   Riese, J ^a   Gerding, H ^a,b  

^a Klinik Pallas   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

anti VEGF; choroidal neovascularisation; Lucentis; pathological myopia; ranibizumab

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MYOPIA; OCULAR SIDE EFFECT; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; SYSTEMIC SIDE EFFECT; VISUAL ACUITY; VISUAL IMPAIRMENT;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; TREATMENT OUTCOME; VISION, LOW; VISUAL ACUITY;

EID: 79953793193     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1273210     Document Type: Article

References (18)

1. Hampton G R., Kohen D, Bird A C. Visual prognosis of disciform degeneration in myopia. Ophthalmology 1983 90 923-926 (Pubitemid 13004305)
2. Miller D G., Singerman L J. Natural history of choroidal neovascularisation in high myopia. Curr Opin Ophthalmol 2001 12 222-224 (Pubitemid 32525956)
3. Cohen S Y., Laroche A, Leguen Y et al. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996 103 1241-1244 (Pubitemid 26282507)
4. Grosvenor T. Why is there an epidemic of Myopia? Clin Exp Ophtam 2003 86 273-275
5. Goldschmidt E. Ocular morbidity in myopia. Acta Ophthalmol Suppl 1988 185 86-87
6. Secratan M, Kuhn D, Soubrane D et al. Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 1997 7 307-316 (Pubitemid 28042043)
7. Blinder K J., Blumenkranz M S., Bressler N M. et al. Verteporfin Therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 2003 110 667-673 (Pubitemid 36520061)
8. Chan A, Blumenkranz M S., Wu K H. et al. Photodynamic therapy with and without adjunctive intravitreal triamcinolone acetonide: a retrospective comparative study. Ophthalmic Surg Lasers Imaging 2009 40 561-569
9. Konstantinidis L, Mantel I, Pournaras J A. et al. Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 2009 247 311-318
10. Lai T Y., Chan W M., Liu D T. et al. Intravitreal ranibizumab for the primary treatment of choroidal neovascularization secondary to pathologic myopia. Retina 2009 29 750-756
11. Silva R M., Ruiz-Moreno J M., Rosa P et al. Intravitreal ranibizumab for myopic choroidal neovascularization: 12 month results. Retina 2010 30 407-412
12. Scupola A, Tiberti A C., Sasso P et al. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results. Retina 2010 30 739-747
13. Ziemsen F, Wiedemann P, Kampik A et al. Intravitreal injections of medications in Germany. Contract situation and legal conditions. Ophthalmologe 2009 106 465-470
14. Laud K, Spaide R F., Freund K B. et al. Treatment of choroidal neovascularization in pathologic myopia with intravitreal bevacizumab. Retina 2006 26 960-963 (Pubitemid 44547453)
15. Ngyen Q D., Shah S, Tatlipinar S et al. Bevacizumab suppresses choroidal neovascularization caused by pathological myopia. Br J Ophthalmol 2005 89 1368-1370 (Pubitemid 41638883)
16. Mones J M., Amselem L, Serrano A et al. Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye 2009 23 1275-1280
17. Torron C, Egea C, Ferrer E et al. Ranibizumab as treatment for myopic choroidal neovascularization. Arch Soc Esp Oftalmol 2009 84 507-514
18. Han D P., Mc Allister J T., Weinberg D V. et al. Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation. Eye 2010 24 713-716